A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients (Q45250754)
scientific article published on 30 May 2010
Language:
(P31) (Q13442814)
(P304) 121-126
(P407) (Q1860)
(P433) 1
(P478) 29
(P577) Sunday, May 30, 2010
(P921) (Q42824440)
(Q5452194)
(Q79460)
(Q1164529)
(Q19000948)
(Q422248)
(P1433) (Q15750774)
(P1476) "A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients" (language: en)
(P2093) M Siebels
K Rohrmann
R Oberneder
M Stahler
N Haseke
J Beck
R Hofmann
M Kindler
P Kloepfer
C Stief
(P2860) (Q28282757)
(Q44774860)
(Q74545965)
(Q28282767)
(Q28364218)
(Q28138094)
(Q29618608)
(Q40570756)
(Q82237213)
(Q68974069)
(Q43843476)
(Q36696911)
(Q74486208)
(Q36509678)
(Q40827792)
(Q34391104)
(Q71542477)
(Q74660708)
(Q28247085)
(Q35157638)
other details
description scientific article published on 30 May 2010

External Links